课题基金 / 基金详情

Determining the Role of Bub1 in T Antigen Mediated Transformation

Determining the Role of Bub1 in T Antigen Mediated Transformation
确定 Bub1 在 T 抗原介导的转化中的作用
批准号:
6989674
负责人:
THOMAS M ROBERTS
金额:
$26.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-27 至 2009-02-28

项目摘要

项目成果

THOMAS M ROBERTS的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经检测到SV 40大T抗原和有丝分裂调节因子Bub 1之间的功能性相互作用。蛋白激酶Bub 1是监测有丝分裂纺锤体组装的检查点蛋白家族的成员,已发现在某些以非整倍性为特征的人类癌症中发生突变。值得注意的是,T抗原还可以通过诱导染色体畸变和非整倍性而引起基因组不稳定性。T抗原与内源性Bub 1以及Bub 3(动粒处检查点复合物的另一种组分)共免疫沉淀。虽然我们认为T抗原是其靶蛋白的灭活剂, 与p53和pRb的情况一样,T实际上增强Bub 1激酶活性。Bub 1磷酸化p53的ser 37,以前确定为一个网站的磷酸化DNA-PK。遗传分析表明,T抗原与Bub 1的相互作用不是永生化所必需的,但似乎是T抗原解除纺锤体组装检查点和转化所必需的。这种与Bub 1的相互作用表明T抗原的新作用,这可能为其调节p53,引起染色体畸变和转化的能力提供新的见解。我们建议详细研究相互作用。我们的目的是确定: (1)Bub 1介导的p53磷酸化的机制后果是什么?(2)除了p53,T抗原是否指导Bub 1朝向其他底物?(3)T抗原是否需要与Bub 1相互作用才能使靶细胞的染色体不稳定?
英文摘要
We have detected a functional interaction between SV40 large T antigen and the mitotic regulator Bub 1. The protein kinase Bub1, a member of the family of checkpoint proteins that monitor the assembly of the mitotic spindle, has been found to be mutated in certain human cancers characterized by aneuploidy. Notably, T antigen can also cause genomic instability by inducing chromosomal aberrations and aneuploidy. T antigen co-immunoprecipitates with endogenous Bub1, as well as with Bub3, another component of the checkpoint complex at the kinetochore. While we have come to think of T antigen as an inactivator of its target proteins as is the case with p53 and pRb, T actually enhances Bub1 kinase activity. Bub1 phosphorylates p53 on ser37, previously identified as a site of phosphorylation by DNA-PK. Genetic analysis demonstrates that interaction of T antigen with Bub1 is not required for immortalization but appears to be necessary for T antigen to deregulate the spindle assembly checkpoint and transform. This interaction with Bub1 suggests a novel role for T antigen, which may provide new insight into its ability to regulate p53, cause chromosome aberrations, and transform. We propose to study the interaction in detail. It is our intent to determine: (1) What are the the mechanistic consequences of Bub1 mediated phosphorylation of p53? (2) Does T antigen direct Bub1 toward other substrates in addition to p53? And (3) Is T antigen's interaction with Bub1 required for T antigen to destabilize the chromosomes in its target cells?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
  • 批准号:
    9816457
  • 项目类别:
  • 资助金额:
    $92.54万
  • 财政年份:
    2019
  • 负责人:
    THOMAS M ROBERTS
  • 依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
  • 批准号:
    10238853
  • 项目类别:
  • 资助金额:
    $104.98万
  • 财政年份:
    2019
  • 负责人:
    THOMAS M ROBERTS
  • 依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
  • 批准号:
    9978752
  • 项目类别:
  • 资助金额:
    $104.98万
  • 财政年份:
    2019
  • 负责人:
    THOMAS M ROBERTS
  • 依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
  • 批准号:
    10705059
  • 项目类别:
  • 资助金额:
    $102.88万
  • 财政年份:
    2019
  • 负责人:
    THOMAS M ROBERTS
  • 依托单位:
海外基金